Compounds > cdp 840
Page last updated: 2024-09-03

cdp 840 and sch 351591

cdp 840 has been researched along with sch 351591 in 1 studies

Compound Research Comparison

Studies
(cdp 840)		Trials
(cdp 840)		Recent Studies (post-2010)
(cdp 840)		Studies
(sch 351591)		Trials
(sch 351591)		Recent Studies (post-2010) (sch 351591)
18031011

Protein Interaction Comparison

ProteinTaxonomycdp 840 (IC50)sch 351591 (IC50)
cAMP-specific 3',5'-cyclic phosphodiesterase 4D Rattus norvegicus (Norway rat)0.15
cAMP-specific 3',5'-cyclic phosphodiesterase 4CRattus norvegicus (Norway rat)0.15
cAMP-specific 3',5'-cyclic phosphodiesterase 4BRattus norvegicus (Norway rat)0.15
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)0.06
cAMP-specific 3',5'-cyclic phosphodiesterase 4ARattus norvegicus (Norway rat)0.15
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.06
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)0.06
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.06

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jabaris, SS; Kodimuthali, A; Pal, M1

Reviews

1 review(s) available for cdp 840 and sch 351591

ArticleYear
Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.
    Journal of medicinal chemistry, 2008, Sep-25, Volume: 51, Issue:18

    Topics: Asthma; Humans; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive

2008